DBV Technologies | Marktkapitalisierung

Created with Highcharts 10.1.0Chart context menu39.5M99.9M170M239M309M379M439M
2022Q32023Q32024Q32025


Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
Alnylam Pharmaceuticals USD 30.35B 4.96B 2024-12
Amarin USD 258M 25M 2024-09
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
DBV Technologies USD 79M 5M 2024-09
Halozyme Therapeutics USD 6.08B 1.17B 2024-12
Incyte USD 13.31B 576M 2024-12
Insmed USD 12.35B 194M 2024-12
Ionis Pharmaceuticals USD 5.52B 791M 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
United Therapeutics USD 15.75B 191M 2024-12



DBV Technologies Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.